This case report presents a rare skin infection caused by Scedosporium apiospermum in an immunosuppressed patient that was successfully diagnosed using next-generation sequencing and treated with surgical debridement and voriconazole.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Case Report
* These authors contributed equally
This case report presents a rare skin infection caused by Scedosporium apiospermum in an immunosuppressed patient that was successfully diagnosed using next-generation sequencing and treated with surgical debridement and voriconazole.
This case report presents a 77-year-old male with purplish-red, blister-like lesions on the right forearm. A background of long-term corticosteroid therapy for pemphigus led to significant immunosuppression. Initial laboratory investigations, including bacterial and fungal cultures as well as histopathological analysis, yielded inconclusive results. To identify the causative pathogen, next-generation sequencing (NGS) was performed on tissue samples, which confirmed the presence of Scedosporium apiospermum, a rare opportunistic fungus. Based on this result, a targeted treatment strategy was implemented, involving multiple surgical debridements and systemic antifungal therapy with voriconazole. The therapeutic response was favorable, with complete resolution of the infection and no signs of recurrence during an 8-month follow-up period. This case highlights the clinical value of NGS in diagnosing rare and atypical infections, particularly in immunocompromised settings where conventional methods may fail. It also underscores the importance of a multidisciplinary treatment approach that integrates timely surgical intervention with appropriate antifungal therapy to achieve optimal patient outcomes.
Skin and soft tissue infections (SSTIs) are among the most frequently encountered conditions in clinical practice, leading to repeated outpatient visits, prolonged hospitalizations, long-term disability, and even mortality. The incidence of SSTIs continues to rise annually, with severe cases often requiring a combination of aggressive surgical intervention and broad-spectrum antimicrobial therapy1.
Although dozens of pathogens may be involved in SSTIs, bacterial infections remain the most common. However, in recent years, the increasing prevalence of geriatric comorbidities and widespread use of immunosuppressive the....
Access restricted. Please log in or start a trial to view this content.
The surgical procedure was approved and conducted per the hospital's ethical committee guidelines.Informed consent was obtained from all individual participants included in the study.
1. Initial evaluation and sample collection
Access restricted. Please log in or start a trial to view this content.
A 77-year-old male with a history of pemphigus under long-term methylprednisolone therapy presented with progressive skin lesions on his right forearm. Initial evaluation, including physical examination (Figure 1) and MRI (Figure 2), revealed two ulcerated lesions with surrounding tissue edema and suspected deep soft tissue infection. Routine exudate culture detected Scedosporium apiospermum, but this was initially regarded as environmental contaminatio.......
Access restricted. Please log in or start a trial to view this content.
Skin is frequently exposed to pathogens, including bacteria, fungi, viruses, rickettsia, and parasites, with Staphylococcus aureus and β-haemolytic streptococci remaining the predominant causes of infection5. In recent decades, fungal skin infections have increased significantly, with mortality rates exceeding 50% among susceptible populations6. Scedosporium apiospermum, in particular, is recognized as a significant human fungal pathogen
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
The study was funded by the National Natural Science Foundation of China (grant number 81702135), Zhejiang Provincial Natural Science Foundation (grant numbers LY20H060007, LS21H060001), and the Zhejiang Traditional Chinese Medicine Research Program (grant number 2017ZB057). The funding bodies had no role in the design of the study, in the collection, analysis, and interpretation of data, or in drafting the manuscript.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Bipolar electrocautery | BAISHENG | 20173251560 | |
| Ceftriaxone | Roche | H10983036 | |
| CLC Genomics Workbench | Qiagen | v23.0 | Data analysis and visualizaion software |
| Corticosteroids | Pfizer | Hj20170197 | |
| DNeasy Blood & Tissue Kit | Qiagen | https://www.qiagen.com/us/products/discovery -and-translational-research/dna -rna-purification/dna-purification /genomic-dna/dneasy-blood-and -tissue-kit | |
| Labeled containers | 3L | N/A | |
| MiSeq | Illumina | https://www.illumina.com/systems/ sequencing-platforms/miseq.html | NGS |
| MiSeq Control Software | Illumina | https://www.illumina.com/systems/ sequencing-platforms/miseq.html | |
| MiSeq Reagent Kit v3 | Illumina | https://www.illumina.com/products/ by-type/sequencing-kits/cluster-gen -sequencing-reagents/miseq- reagent-kit-v3.html | |
| MRI | SIEMENS | 3146466 | |
| Nextera XT DNA Library Prep Kit | Illumina | https://www.illumina.com/products /by-type/sequencing-kits/library- prep-kits/nextera-xt-dna.html | DNA Library Prep Kit |
| QIAamp DNA Mini Kit | Qiagen | 51304 | DNA extraction kit |
| Qubit dsDNA HS Assay Kit | Thermo Fisher Scientific | https://www.thermofisher.com/in/en /home/industrial/spectroscopy- elemental-isotope-analysis/ molecular-spectroscopy/fluorometers /qubit/qubit-assays.html?ef_id=: G:s&s_kwcid=AL!3652!10!775157 26968096!!!!77515743318006!!3 80468453!1240249321530142& cid=bid_pca_aqb_r01_co_cp1359_pj t0000_bid00000_0se_bng_bt_pur_con | |
| Scalpel | JZ | 20140019 | |
| Sterile swab | Meidike Gene | MWS001 | |
| Voriconazole | Pfizer | H20150168 |
Access restricted. Please log in or start a trial to view this content.
This article has been published
Video Coming Soon